Stock Market

Joby (NYSE:JOBY) appears to have most of the ingredients necessary to enable JOBY stock to (pardon the pun) eventually take off. Source: T. Schneider / Shutterstock.com Specifically, the air-taxi company has proven technology, a service that should generate strong demand, a highly accomplished CEO, impressive backers and a fairly reasonable valuation. When it comes to

The electric vehicle (EV) trade has finally cooled off, which is a good thing given how far it had run. It would be hard for Tesla (NASDAQ:TSLA) to justify a trillion dollar market capitalization or for these revenue-less SPAC stocks to keep soaring higher. Meanwhile, Nio (NYSE:NIO) is somewhere in between, with NIO stock performing

Time recently named Nvidia (NASDAQ:NVDA) CEO and founder Jensen Huang one of its 100 most influential people. If you invested $10,000 in NVDA stock in its 1999 IPO, it would be worth $8.5 million today. Source: Hairem / Shutterstock.com My guess if you’re one of these lucky shareholders is that you would also feel Huang

Chinese electric vehicle (EV) maker Nio (NYSE:NIO) has seen its shares take another tumble as of late. On Monday, NIO stock closed down 6.2% on the day. At this point, NIO stock is down nearly 27% in 2021. For investors, that’s a gut-wrenching turn in direction for a stock that delivered a 1,110% return last year.

What would happen if a company developed a massive new product and no one cared? For Pfizer’s (NYSE:PFE) investors, that has been the question for the past year. Despite coming up with a blockbuster vaccine for the novel coronavirus, PFE stock did basically nothing for an extended period. Source: Manuel Esteban / Shutterstock.com That finally changed

The September slump on Wall Street took a turn for the worse yesterday, as stocks plunged on Monday in their worst sell-off since July. Even with a huge end-of-day bounce, the Dow Jones still closed down 1.7%, while the S&P 500 shed 1.6% and the Nasdaq tumbled 2.2%. Source: Shutterstock The catalyst? It wasn’t obvious.

Since biotechnology company Cassava Sciences (NASDAQ:SAVA) is working hard to fight Alzheimer’s disease, it might be surprising to know that the company has some harsh critics. There’s a lot of drama going on with Cassava, and SAVA stock traders need to be aware of the latest developments. Source: Atthapon Raksthaput / Shutterstock.com Just to give you

Epic Games has handed Apple (NASDAQ:AAPL) an epic defeat. Epic Systems, the maker of “Fortnite” and other popular games, launched a massive lawsuit against the company years ago for allegedly anticompetitive behavior. And, in a surprise to many observers, a judge largely agreed. Source: Shutterstock On Sept. 10, a judge ruled on the long-running Epic

Sentiment on Wall Street has taken a turn for the worse of late. Overall the bulls are still in control of the charts. However, the bears have recently made progress. The good news that it’s more to do with sentiment than actual fundamental deterioration in the macroeconomic conditions. This is my long way of saying

It’s all about the miles, sort of, with Lucid (NASDAQ:LCID) stock popping 10% since yesterday on positive reports about its range. Source: ggTravelDiary / Shutterstock.com According to the U.S. Environmental Protection Agency, the Lucid Air Dream edition can go 520 miles on one charge. That is 20% longer than Tesla (NASDAQ:TSLA), so that’s quite an

Will you invest with fear, or with guts and glory? That’s the billion-dollar question facing each and every Alibaba (NYSE:BABA) shareholder now as BABA stock continues to drift downward with no mercy. Source: Nopparat Khokthong / Shutterstock.com I can fully understand why some investors might want to avoid Alibaba and Chinese businesses altogether. It’s not about

If you are a contrarian investor, you may believe that Roku, Inc. (NASDAQ: ROKU) has underperformed the broader market in 2021  and is now an investment opportunity. In 2021, ROKU stock is down nearly 6% compared to gains of about 18% for the S&P 500. Source: Michael Vi / Shutterstock.com Being a contrarian investor has

I’m all about finding the next big thing in the electric vehicle (EV) space to unseat Tesla (TSLA). Forget what’s big today. Capitalism is defined by creative destruction. Nothing lasts forever in an economy where we are all incentivized to always go bigger, do better, and be stronger. Just look at a list of the

Last weekend was the first weekend of the 2021-22 NFL season, and it looked a lot different than last year’s opening weekend. Source: sutadimages / Shutterstock New faces on new teams. Fans in the stadium. Ratings are back up. Oh, and everyone is suddenly betting. Sports betting volume over the first weekend of the NFL

I’ve been a fan of financial technology stocks for a long while. Up until recently the choices were a few, and pretty much limited to Visa (NYSE:V), MasterCard (NYSE:MA) or American Express (NYSE:AXP). During the last few years, two worthy competitors entered the arena: PayPal (NASDAQ:PYPL) and Square (NYSE:SQ). Even more recently, more companies like

There’s no getting around it: it’s all about that $15 resistance level for folks who own Ocugen (NASDAQ:OCGN) shares. Frustratingly, OCGN stock bumped its head against that price point in February, and then again in May. Source: Shutterstock It’s a legitimate question: how are the buyers finally going to get a sustainable rally going? Without a

Joby Aviation (NYSE:JOBY) is a firm focused on urban air mobility. Bulls liken it to a combination of Tesla (NASDAQ:TSLA) and Uber (NYSE:UBER) with the added bonus of using the atmosphere to avoid ground-based traffic congestion and terrain-induced obstacles. On paper, JOBY stock should be soaring given this appealing concept. Source: T. Schneider / Shutterstock.com However,

The last story I wrote on Oracle (NYSE:ORCL) covered the company’s difficult, but largely successful transition to cloud computing from the traditional on-premise software business. The results have been mixed for ORCL stock so far. I last said, “So in order to adopt to the new technology standard, ORCL simply added cloud to the end

In the 1980s, the field of genetics surged in popularity. At the time, I’m sure there were many articles promising investors that genetics stocks were on the cusp of spectacular gains. Investors who were looking for short-term payoffs then were disappointed, but now, gene editing stocks look far more promising. Researching the genetic origin behind

The story of Hippo Holdings (NYSE:HIPO) stock had an inauspicious beginning. The homeowners insurance provider emerged from a special purpose acquisition company (SPAC) deal that soured in the eleventh hour. Now, investors are wondering if HIPO stock is worth a buy. Source: MIND AND I / Shutterstock.com InvestorPlace’s own Robert Lakin did an excellent job